Xoma reported $5.42M in Current Liabilities for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Agenus AGEN:US USD 173.07M 13.35M
Agios Pharmaceuticals AGIO:US USD 53.6M 5.2M
Ardelyx ARDX:US USD 51.95M 3.25M
Biomarin Pharmaceutical BMRN:US USD 521.02M 56.29M
Bluebird Bio BLUE:US USD 126.73M 22.13M
Celldex Therapeutics CLDX:US USD 16.29M 13.66M
Chimerix CMRX:US USD 17.71M 5.56M
Curis CRIS:US USD 13.74M 1.59M
Emergent Biosolutions EBS:US USD 268.4M 8.3M
Intercept Pharmaceuticals ICPT:US USD 221.58M 70.16M
Life Technologies LIFE:US USD 11.21M 1.95M
Macrogenics MGNX:US USD 50.05M 831K
Novartis NOVN:VX USD 28.66B 496M
Novartis NVS:US USD 28.66B 496M
Prothena PRTA:US USD 50.6M 10.49M
Regeneron Pharmaceuticals REGN:US USD 3.85B 969.9M
Teva Pharmaceutical Industries TEVA:US USD 11.53B 538M
Xoma XOMA:US USD 5.42M 3M